2000 Fiscal Year Final Research Report Summary
Investigation For Molecular Mechanism Of Insulin Resistance In Transgenic Mice Expressing A Mutant Shp2
| Project/Area Number |
10671062
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Metabolomics
|
|---|
| Research Institution | Shiga University Of Medical Science |
|---|
Principal Investigator |
MAEGAWA Hiroshi Shiga University Of Medical Science, Faculty Of Medicine, Rasearch Associates, 医学部, 助手 (00209363)
|
|---|
| Project Period (FY) |
1998 – 2000
|
| Keywords | Protein-Tyrosine Phosphatase / SHP-2 / Transgenic Mice / Insulin Resistance / Protein phosphatase |
|---|
| Research Abstract |
To elucidate roles of SHP-2, we generated transgenic (Tg) mice expressing a dominant negative mutant lacking PTPase domain (DPTP). On examining 2 lines of Tg mice identified by Southern blot, the transgene product was expressed in skeletal muscle liver and adipose tissues and insulin-induced association of insulin receptor substrate (IRS) 1 with endogenous SHP-2 was inhibited, confirming that DPTP has a dominant negative property. The intraperitoneal glucose loading test demonstrated an increase in blood glucose levels in Tg mice. Plasma insulin levels in Tg mice after 4 h fasting were 3 times greater with comparable blood glucose levels. To estimate insulin sensitivity by a constant glucose, insulin and somatostatin infusion, steady state blood glucose levels were higher, suggesting the presence of insulin resistance. Furthermore we observed the impairment of insulin-stimulated glucose uptake in muscle and adipocytes in the presence of physiological concentrations of insulin. Moreover, tyrosine-phosphorylation of IRS-1 and stimulation of phosphatidylinositol 3-kinase and Akt kinase activities by insulin were attenuated in muscle and liver. These results indicate that the inhibition of endogenous SHP-2 function by the overexpression of a dominant negative mutant may lead to impaired insulin sensitivity of glucose metabolism and thus SHP-2 may function to modulate insulin signaling in target tissues and these Tg mice are a unique model to investigate molecular mechanism for insulin resistance.
|
-
-
-
-
-
-
-
-
-
[Publications] Maegawa H, Obata T, Shibata T, Fujita T, Ugi S, Morino K, Nishio Y, Kojima H, Hidaka H, Haneda M, Yasuda H, Kikkawa R and Kashiwagi A.: "A new antidiabetic agent (JTT-501) acutely stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle."Diabetologia. 42. 151-159 (1999)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Maegawa H, Shi K, Hidaka H, Iwai N, Nishio Y, Egawa K, Kojima H, Haneda M, Yasuda H, Nakamura Y, Kinoshita M, Kikkawa R and Kashiwagi A.: "The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in Japanese Type 2 diabetes mellitus."Diabetes. 48. 1469-1472 (1999)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Maegawa H, Hasegawa M, Sugai S, Ugi S, Obata T, Morino K, Egawa K, Fujita T, Sakamoto T, Nishio Y, Kojima H, Haneda M, Yasuda H, Kikkawa R and Kashiwagi A.: "Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance."J.Biol.Chem.. 274. 30236-43 (1999)
Description
「研究成果報告書概要(欧文)」より
-
-
-
